Skip to main content

and
  1. Article

    Open Access

    Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat

    Glucagon-like peptide-1 (GLP-1) and its mimetics reduce infarct size in the setting of acute myocardial ischemia/reperfusion (I/R) injury. However, the short serum half-life of GLP-1 and its mimetics may limit...

    Weike Bao, Lucy J Holt, Rob D Prince, Gavin X Jones in Cardiovascular Diabetology (2013)

  2. No Access

    Article

    Lysophosphatidylcholine induces inflammatory activation of human coronary artery smooth muscle cells

    Lysophosphatidylcholine (LPC) is the major bioactive lipid component of oxidized LDL, thought to be responsible for many of the inflammatory effects of oxidized LDL described in both inflammatory and endotheli...

    Nambi Aiyar, Jyoti Disa, Zhaohui Ao, Haisong Ju in Molecular and Cellular Biochemistry (2007)

  3. No Access

    Protocol

    Quantitative Analysis of Orphan G Protein-Coupled Receptor mRNAs by TaqMan® Real-Time PCR

    Historically, the G protein-coupled receptor (GPCR) protein family has proven to be an extremely tractable target class (1). It is estimated that approximately one-half of all drugs currently marketed exert their...

    Stephen A. Douglas, Zhaohui Ao, Douglas G. Johns in Receptor Binding Techniques (2005)

  4. No Access

    Article

    Urotensin-II: a novel systemic hypertensive factor in the cat

    Urotensin-II, a potent mammalian vasoconstrictor, may play a role in the etiology of essential hypertension. However, a species suitable for assessing such a role, one where a “classical” systemic hypertensive...

    David J. Behm, Christopher P. A. Doe in Naunyn-Schmiedeberg's Archives of Pharmaco… (2004)

  5. No Access

    Chapter

    p38 MAPK in cardiac remodeling and failure: cytokine signaling and beyond

    Compelling evidence suggests that a complex interplay between various mitogenactivated protein kinases (MAPK) mediate adaptive and maladaptive changes in the myocardium. MAPKs are serine-threonine protein kina...

    Thomas M. Behr, Christopher P. Doe, Ju Haisong in Inflammation and Cardiac Diseases (2003)

  6. Article

    Erratum: Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

    Nature 401, 282–286; 1999 Units for the x-axis of Fig. 5b–g should be pmol kg -1 (and not nmol kg-1 as published). In Fig. 5f, the right numeral should be 1,000.

    Robert S. Ames, Henry M. Sarau, Johathan K. Chambers, Robert N. Willette in Nature (1999)

  7. No Access

    Article

    Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

    Urotensin-II (U-II) is a vasoactive ‘somatostatin-like’ cyclic peptide which was originally isolated from fish spinal cords1,2, and which has recently been cloned from man3. Here we describe the identification of...

    Robert S. Ames, Henry M. Sarau, Johathan K. Chambers, Robert N. Willette in Nature (1999)

  8. No Access

    Chapter

    Comparing Porcine Models of Coronary Restenosis

    The use of swine to study the vascular response to injury has gained wide acceptance over the past 10 yr. Our approach to the porcine model has been focused on the evaluation of novel therapeutic approaches to...

    Robert N. Willette, Hong Zhang, Calvert Louden in Advances in Swine in Biomedical Research (1996)